{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:56:18Z","timestamp":1790556978026,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI162242; R01AI161010; UM1AI164570; P30 AI064518"],"award-info":[{"award-number":["P01AI162242; R01AI161010; UM1AI164570; P30 AI064518"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI162242; R01AI161010; UM1AI164570; P30 AI064518"],"award-info":[{"award-number":["P01AI162242; R01AI161010; UM1AI164570; P30 AI064518"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI162242; R01AI161010; UM1AI164570; P30 AI064518"],"award-info":[{"award-number":["P01AI162242; R01AI161010; UM1AI164570; P30 AI064518"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI162242; R01AI161010; UM1AI164570; P30 AI064518"],"award-info":[{"award-number":["P01AI162242; R01AI161010; UM1AI164570; P30 AI064518"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03223-0","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:27:25Z","timestamp":1783319245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ADAM17 blockade restores natural killer cell antibody-dependent cytotoxicity against human immunodeficiency virus-1"],"prefix":"10.1186","volume":"23","author":[{"given":"Sho","family":"Sugawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griffin","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3157-2557","authenticated-orcid":false,"given":"R. Keith","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"3223_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009101","volume":"16","author":"T Mdluli","year":"2020","unstructured":"Mdluli T, Jian N, Slike B, Paquin-Proulx D, Donofrio G, Alrubayyi A, et al. RV144 HIV-1 vaccination impacts post-infection antibody responses. PLoS Pathog. 2020;16:e1009101. https:\/\/doi.org\/10.1371\/journal.ppat.1009101.","journal-title":"PLoS Pathog"},{"key":"3223_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020079","volume":"2","author":"Y Qi","year":"2006","unstructured":"Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S, et al. KIR\/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2006;2:e79. https:\/\/doi.org\/10.1371\/journal.ppat.0020079.","journal-title":"PLoS Pathog"},{"key":"3223_CR3","doi-asserted-by":"publisher","unstructured":"Vieillard V, Fausther-Bovendo H, Samri A, Debre P. and French Asymptomatiques a Long Terme, A.-C.O.S.G. (2010). Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers. J Acquir Immune Defic Syndr 53, 564\u201373. https:\/\/doi.org\/10.1097\/QAI.0b013e3181d0c5b4","DOI":"10.1097\/QAI.0b013e3181d0c5b4"},{"key":"3223_CR4","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.1128\/JVI.01420-14","volume":"88","author":"F Ahmad","year":"2014","unstructured":"Ahmad F, Hong HS, Jackel M, Jablonka A, Lu IN, Bhatnagar N, et al. High frequencies of polyfunctional CD8\u2009+\u2009NK cells in chronic HIV-1 infection are associated with slower disease progression. J Virol. 2014;88:12397\u2013408. https:\/\/doi.org\/10.1128\/JVI.01420-14.","journal-title":"J Virol"},{"key":"3223_CR5","doi-asserted-by":"publisher","unstructured":"Woolley G, Mosher M, Kroll K, Jones R, Hueber B, Sugawara S, et al. Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events. J Virol. 2022(1). https:\/\/doi.org\/10.1128\/jvi.01519-22.","DOI":"10.1128\/jvi.01519-22"},{"key":"3223_CR6","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.xcrm.2022.100773","volume":"3","author":"KW Kroll","year":"2022","unstructured":"Kroll KW, Shah SV, Lucar OA, Premeaux TA, Shikuma CM, Corley MJ, Mosher M, Woolley G, Bowler S, Ndhlovu LC, Reeves RK. Mucosal-homing natural killer cells are associated with aging in persons living with HIV. Cell Rep Med. 2022;3:100773. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100773.","journal-title":"Cell Rep Med"},{"key":"3223_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007730","volume":"6","author":"NL Yates","year":"2014","unstructured":"Yates NL, Liao HX, Fong Y, deCamp A, Vandergrift NA, Williams WT, et al. Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci Transl Med. 2014;6:228ra239. https:\/\/doi.org\/10.1126\/scitranslmed.3007730.","journal-title":"Sci Transl Med"},{"key":"3223_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 2007;449:101\u20134. https:\/\/doi.org\/10.1038\/nature06106.","journal-title":"Nature"},{"key":"3223_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0161-5890(92)90018-s","volume":"29","author":"TE Michaelsen","year":"1992","unstructured":"Michaelsen TE, Aase A, Norderhaug L, Sandlie I. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region. Mol Immunol. 1992;29:319\u201326. https:\/\/doi.org\/10.1016\/0161-5890(92)90018-s.","journal-title":"Mol Immunol"},{"key":"3223_CR10","doi-asserted-by":"publisher","unstructured":"Alpert MD, Harvey JD, Lauer WA, Reeves RK, Piatak M Jr., Carville A, et al. ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. PLoS Pathog. 2012;8:e1002890. https:\/\/doi.org\/10.1371\/journal.ppat.1002890.","DOI":"10.1371\/journal.ppat.1002890"},{"key":"3223_CR11","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1182\/blood-2005-03-1100","volume":"106","author":"G Alter","year":"2005","unstructured":"Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, Waring MT, et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood. 2005;106:3366\u20139. https:\/\/doi.org\/10.1182\/blood-2005-03-1100.","journal-title":"Blood"},{"key":"3223_CR12","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1073\/pnas.0409872102","volume":"102","author":"D Mavilio","year":"2005","unstructured":"Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, et al. Characterization of CD56-\/CD16 + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A. 2005;102:2886\u201391. https:\/\/doi.org\/10.1073\/pnas.0409872102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3223_CR13","doi-asserted-by":"publisher","unstructured":"Milush JM, Lopez-Verges S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF. CD56negCD16(+) NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology. 2013;10. https:\/\/doi.org\/10.1186\/1742-4690-10-158.","DOI":"10.1186\/1742-4690-10-158"},{"key":"3223_CR14","doi-asserted-by":"publisher","unstructured":"Pohlmeyer CW, Gonzalez VD, Irrinki A, Ramirez RN, Li L, Mulato A, Murry JP, Arvey A, Hoh R, Deeks SG, et al. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control. J Virol. 2019;93. https:\/\/doi.org\/10.1128\/JVI.01790-18.","DOI":"10.1128\/JVI.01790-18"},{"key":"3223_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1089\/AID.2017.0095","volume":"33","author":"MZ Zulu","year":"2017","unstructured":"Zulu MZ, Naidoo KK, Mncube Z, Jaggernath M, Goulder PJR, Ndung\u2019u T, et al. Reduced expression of Siglec-7, NKG2A, and CD57 on terminally differentiated CD56(-)CD16(+) natural killer cell subset is associated with natural killer cell dysfunction in chronic HIV-1 clade C infection. AIDS Res Hum Retroviruses. 2017;33:1205\u201313. https:\/\/doi.org\/10.1089\/AID.2017.0095.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3223_CR16","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1084\/jem.20060894","volume":"203","author":"D Mavilio","year":"2006","unstructured":"Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, Ortolano S, et al. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med. 2006;203:2339\u201350. https:\/\/doi.org\/10.1084\/jem.20060894.","journal-title":"J Exp Med"},{"key":"3223_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00222","volume":"5","author":"AG Kulkarni","year":"2014","unstructured":"Kulkarni AG, Paranjape RS, Thakar MR. Higher expression of activating receptors on cytotoxic NK cells is associated with early control on HIV-1C multiplication. Front Immunol. 2014;5:222. https:\/\/doi.org\/10.3389\/fimmu.2014.00222.","journal-title":"Front Immunol"},{"key":"3223_CR18","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/eji.200635901","volume":"36","author":"ML LaBonte","year":"2006","unstructured":"LaBonte ML, McKay PF, Letvin NL. Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C\/C2 expression. Eur J Immunol. 2006;36:2424\u201333. https:\/\/doi.org\/10.1002\/eji.200635901.","journal-title":"Eur J Immunol"},{"key":"3223_CR19","doi-asserted-by":"publisher","unstructured":"Ries M, Reynolds MR, Bashkueva K, Crosno K, Capuano S 3rd, Prall TM, et al. KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques. PLoS Pathog. 2017;13:e1006506. https:\/\/doi.org\/10.1371\/journal.ppat.1006506.","DOI":"10.1371\/journal.ppat.1006506"},{"key":"3223_CR20","doi-asserted-by":"publisher","first-page":"8705","DOI":"10.1128\/JVI.02666-08","volume":"83","author":"Q Liu","year":"2009","unstructured":"Liu Q, Sun Y, Rihn S, Nolting A, Tsoukas PN, Jost S, Cohen K, Walker B, Alter G. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J Virol. 2009;83:8705\u201312. https:\/\/doi.org\/10.1128\/JVI.02666-08.","journal-title":"J Virol"},{"key":"3223_CR21","doi-asserted-by":"publisher","first-page":"e53251","DOI":"10.1371\/journal.pone.0053251","volume":"8","author":"V Naranbhai","year":"2013","unstructured":"Naranbhai V, Altfeld M, Karim SS, Ndung\u2019u T, Karim QA, Carr WH. Changes in Natural Killer cell activation and function during primary HIV-1 Infection. PLoS ONE. 2013;8:e53251. https:\/\/doi.org\/10.1371\/journal.pone.0053251.","journal-title":"PLoS ONE"},{"key":"3223_CR22","doi-asserted-by":"publisher","first-page":"e1011629","DOI":"10.1371\/journal.ppat.1011629","volume":"19","author":"S Sugawara","year":"2023","unstructured":"Sugawara S, Hueber B, Woolley G, Terry K, Kroll K, Manickam C, Ram DR, Ndhlovu LC, Goepfert P, Jost S, Reeves RK. Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18\/ADAM17-dependent mechanism. PLoS Pathog. 2023;19:e1011629. https:\/\/doi.org\/10.1371\/journal.ppat.1011629.","journal-title":"PLoS Pathog"},{"key":"3223_CR23","doi-asserted-by":"publisher","DOI":"10.1089\/AID.2023.0114","author":"S Sugawara","year":"2024","unstructured":"Sugawara S, Lee E, Craemer MA, Pruitt A, Balachandran H, Gressens SB, Kroll K, Manickam C, Li Y, Jost S, et al. Knockdowns of CD3zeta Chain in Primary NK Cells Illustrate Modulation of Antibody-Dependent Cellular Cytotoxicity Against Human Immunodeficiency Virus-1. AIDS Res Hum Retroviruses. 2024. https:\/\/doi.org\/10.1089\/AID.2023.0114.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3223_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fimmu.2016.00101","volume":"7","author":"CM Nielsen","year":"2016","unstructured":"Nielsen CM, Wolf AS, Goodier MR, Riley EM. Synergy between Common gamma Chain Family Cytokines and IL-18 Potentiates Innate and Adaptive Pathways of NK Cell Activation. Front Immunol. 2016;7:101. https:\/\/doi.org\/10.3389\/fimmu.2016.00101.","journal-title":"Front Immunol"},{"key":"3223_CR25","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1182\/blood-2012-04-425397","volume":"121","author":"R Romee","year":"2013","unstructured":"Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, Luo X, Cooley S, Verneris M, Walcheck B, Miller J. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood. 2013;121:3599\u2013608. https:\/\/doi.org\/10.1182\/blood-2012-04-425397.","journal-title":"Blood"},{"key":"3223_CR26","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1172\/JCI135557","volume":"130","author":"M Tuyishime","year":"2020","unstructured":"Tuyishime M, Garrido C, Jha S, Moeser M, Mielke D, LaBranche C, Montefiori D, Haynes BF, Joseph S, Margolis DM, Ferrari G. Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies. J Clin Invest. 2020;130:5157\u201370. https:\/\/doi.org\/10.1172\/JCI135557.","journal-title":"J Clin Invest"},{"key":"3223_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Kerbauy N, Overman L, Thall B, Kaplan P, M., et al. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. N Engl J Med. 2020;382:545\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1910607.","journal-title":"N Engl J Med"},{"key":"3223_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-1-4939-3684-7_28","volume":"1441","author":"M Felices","year":"2016","unstructured":"Felices M, Lenvik TR, Davis ZB, Miller JS, Vallera DA. Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells. Methods Mol Biol. 2016;1441:333\u201346. https:\/\/doi.org\/10.1007\/978-1-4939-3684-7_28.","journal-title":"Methods Mol Biol"},{"key":"3223_CR29","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1158\/1078-0432.CCR-15-2710","volume":"22","author":"DA Vallera","year":"2016","unstructured":"Vallera DA, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl JU, Zhang B, Lenvik AJ, Panoskaltsis-Mortari A, Verneris MR, et al. IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33\u2009+\u2009Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clin Cancer Res. 2016;22:3440\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2710.","journal-title":"Clin Cancer Res"},{"key":"3223_CR30","doi-asserted-by":"publisher","unstructured":"Bardhi A, Wu Y, Chen W, Li W, Zhu Z, Zheng JH, Wong H, Jeng E, Jones J, Ochsenbauer C et al. (2017). Potent In Vivo NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein. J Virol 91. https:\/\/doi.org\/10.1128\/JVI.00937-17","DOI":"10.1128\/JVI.00937-17"},{"key":"3223_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jimmun\/vkae028","volume":"214","author":"C Tomescu","year":"2025","unstructured":"Tomescu C, Ochoa-Ortiz A, Lu LD, Kong H, Riley JL, Montaner LJ. Gene-modified NK cells expressing CD64 and preloaded with HIV-specific BNAbs target autologous HIV-1-infected CD4\u2009+\u2009T cells by ADCC. J Immunol. 2025;214:253\u201364. https:\/\/doi.org\/10.1093\/jimmun\/vkae028.","journal-title":"J Immunol"},{"key":"3223_CR35","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/JLB.2MR1218-501R","volume":"105","author":"J Wu","year":"2019","unstructured":"Wu J, Mishra HK, Walcheck B. Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy. J Leukoc Biol. 2019;105:1297\u2013303. https:\/\/doi.org\/10.1002\/JLB.2MR1218-501R.","journal-title":"J Leukoc Biol"},{"key":"3223_CR36","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1182\/blood-2011-05-351411","volume":"118","author":"S Veeramani","year":"2011","unstructured":"Veeramani S, Wang SY, Dahle C, Blackwell S, Jacobus L, Knutson T, Button A, Link BK, Weiner GJ. Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism. Blood. 2011;118:3347\u20139. https:\/\/doi.org\/10.1182\/blood-2011-05-351411.","journal-title":"Blood"},{"key":"3223_CR37","doi-asserted-by":"publisher","unstructured":"Cox MC, Battella S, La Scaleia R, Pelliccia S, Di Napoli A, Porzia A, Cecere F, Alma E, Zingoni A, Mainiero F et al. (2015). Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients. Oncoimmunology 4, e990773. https:\/\/doi.org\/10.4161\/2162402X.2014.990773","DOI":"10.4161\/2162402X.2014.990773"},{"key":"3223_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ymthe.2019.10.009","volume":"28","author":"EJ Pomeroy","year":"2020","unstructured":"Pomeroy EJ, Hunzeker JT, Kluesner MG, Lahr WS, Smeester BA, Crosby MR, Lonetree CL, Yamamoto K, Bendzick L, Miller JS, et al. A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy. Mol Ther. 2020;28:52\u201363. https:\/\/doi.org\/10.1016\/j.ymthe.2019.10.009.","journal-title":"Mol Ther"},{"key":"3223_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121788","volume":"10","author":"Y Jing","year":"2015","unstructured":"Jing Y, Ni Z, Wu J, Higgins L, Markowski TW, Kaufman DS, et al. Identification of an ADAM17 cleavage region in human CD16 (Fc\u03b3RIII) and the engineering of a non-cleavable version of the receptor in NK cells. PLoS One. 2015;10:e0121788. https:\/\/doi.org\/10.1371\/journal.pone.0121788.","journal-title":"PLoS One"},{"issue":"1","key":"3223_CR40","doi-asserted-by":"publisher","first-page":"9915","DOI":"10.1038\/s41467-025-64862-5","volume":"16","author":"BT da Silva Bortoleti","year":"2025","unstructured":"da Silva Bortoleti BT, Quasem S, Maurer S, Zhong X, Pimenta R, Ribeiro de Lima Brandao L, et al. A monoclonal antibody that inhibits the shedding of CD16a and CD16b and promotes antibody-dependent cellular cytotoxicity against tumors. Nat Commun. 2025;16:9915. https:\/\/doi.org\/10.1038\/s41467-025-64862-5.","journal-title":"Nat Commun"},{"key":"3223_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41811-z","volume":"9","author":"RN Mohammed","year":"2019","unstructured":"Mohammed RN, Wehenkel SC, Galkina EV, Yates EK, Preece G, Newman A, et al. ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells. Sci Rep. 2019;9:5487. https:\/\/doi.org\/10.1038\/s41598-019-41811-z.","journal-title":"Sci Rep"},{"key":"3223_CR42","doi-asserted-by":"publisher","unstructured":"Qualls AE, Tsao T, Lui I, Lim SA, Su Y, Chen E, Duchen D, Maecker HT, Kim-Schulze S, Montgomery RR, et al. High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19. JCI Insight. 2025;10. https:\/\/doi.org\/10.1172\/jci.insight.191314.","DOI":"10.1172\/jci.insight.191314"},{"key":"3223_CR43","doi-asserted-by":"crossref","unstructured":"Koene HR, Kleijer M, Algra J, Roos D. dem Borne, A.E., and de Haas, M. (1997). Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L\/R\/H phenotype. Blood 90, 1109\u20131114.","DOI":"10.1182\/blood.V90.3.1109"},{"key":"3223_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00384","volume":"7","author":"MR Goodier","year":"2016","unstructured":"Goodier MR, Lusa C, Sherratt S, Rodriguez-Galan A, Behrens R, Riley EM. Sustained immune complex-mediated reduction in CD16 expression after vaccination regulates NK cell function. Front Immunol. 2016;7:384. https:\/\/doi.org\/10.3389\/fimmu.2016.00384.","journal-title":"Front Immunol"},{"key":"3223_CR45","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1073\/pnas.1016048108","volume":"108","author":"AW Chung","year":"2011","unstructured":"Chung AW, Isitman G, Navis M, Kramski M, Center RJ, Kent SJ, et al. Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure. Proc Natl Acad Sci U S A. 2011;108:7505\u201310. https:\/\/doi.org\/10.1073\/pnas.1016048108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3223_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cyto.b.21515","volume":"94","author":"O Mizrahi","year":"2018","unstructured":"Mizrahi O, Ish Shalom E, Baniyash M, Klieger Y. Quantitative flow cytometry: concerns and recommendations in clinic and research. Cytometry B Clin Cytom. 2018;94:211\u20138. https:\/\/doi.org\/10.1002\/cyto.b.21515.","journal-title":"Cytometry B Clin Cytom"},{"key":"3223_CR47","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","volume":"549","author":"HS Venkatesh","year":"2017","unstructured":"Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, et al. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature. 2017;549:533\u20137. https:\/\/doi.org\/10.1038\/nature24014.","journal-title":"Nature"},{"key":"3223_CR48","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.celrep.2018.11.020","volume":"25","author":"SV Shah","year":"2018","unstructured":"Shah SV, Manickam C, Ram DR, Kroll K, Itell H, Permar SR, et al. CMV primes functional alternative signaling in adaptive \u0394g NK cells but is subverted by lentivirus infection in Rhesus Macaques. Cell Rep. 2018;25:2766-2774 e2763. https:\/\/doi.org\/10.1016\/j.celrep.2018.11.020.","journal-title":"Cell Rep"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03223-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:19:55Z","timestamp":1790554795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03223-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3223"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03223-0","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained under IRB\u2013approved protocols at the respective institutions and commercial providers, and all donors provided written informed consent; this study used only de-identified donated blood cells and did not involve direct participant interaction, so additional consent to participate was not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"223"}}